Which Dividend King Wins The Throne: P&G Or Colgate-Palmolive?
Consumer products companies have been among the most rewarding dividend stocks to own over long periods of time. Take industry behemoths Procter & Gamble (PG) and Colgate-Palmolive (CL) as prime examples. P&G has paid a dividend for 127 years, and has increased its dividend for 60 years in a row. Colgate-Palmolive began paying dividends to […]
Is There More Room To The Upside Morgan Stanley Stock?
On the face of it, Morgan Stanley (MS) stock is looking solid right now. Around November 7, 2016, the stock was trading at $33 per share, but the surprise election of Donald Trump scented into the stratosphere. A month of unprecedented gains so MS stock rising above $40 per share, and consolidating in a tight […]
Workday Delivers Impressive Quarter, Market Not Thrilled
SaaS-based enterprise application services provider Workday (NYSE: WDAY) may have delivered an impressive quarter, but the market is not impressed. During the recent result announcement, Workday announced a change in accounting practices and a re-organization of its operations – a move that has not gone down well with the analysts. Photo Credit: theaucitron/Flickr.com Workday’s Financials Workday’s fourth […]
Year-Over-Year Import Prices At Highest Level In Five Years: Inflation Scare Or The Real Deal?
In February, import prices rose 0.2% in line with the Econoday consensus. Export prices rose 0.3%, slightly more than the consensus estimate of 0.2%. Revisions took upped January import prices from 0.4% to 0.6% and export prices from 0.1% to 0.2%. Year-over-year import prices jumped from 3.7% to 4.6% and export prices from 2.3% to 3.1%. Econoday cites […]
4 Top-Ranked Small-Cap Blend Mutual Funds To Consider
Small-cap blend funds are a type of equity mutual funds that offer a mix of value and growth stocks, the market capitalization of which are generally lower than $2 billion. Blend funds are also known as “hybrid funds.” Blend funds aim for value appreciation by capital gains. These funds owe their origin to a graphical […]
Biotech Seen Returning To Outperformance Despite Political, Pricing Risks
UBS analyst Carter Gould started coverage of several biotech names with a Buy rating, saying he finds bullish signals amid the noise and expects the sector to return to outperformance, overcoming continued political and pricing risks. Nonetheless, he recommends taking a “selective approach” to the space as continued growth headwinds should remain pertinent for some […]
Bad News For Wall Street: No Tax Reform Until Fiscal 2018, McConnell Warns
As explained, most recently two days ago, the key reason Wall Street is concerned about the complications involving Obamacare’s “repeal and replace”, which now appears will be stuck in Congress for a long time following vocal opposition from various conservative groups and outside lobby interests, is that it will delay tax reform. As Goldman laid it […]
Another Timber Splits
I’m having to carefully monitor my emotional state as it relates to my decision-making because things have been going far too smoothly lately. My portfolio is gaining in value day after day, almost irrespective of the market. In spite of this giddiness, I’ll share another observation: the emerging markets, which I shorted yesterday in size, slipped […]
Separating Reality From Catastrophe
WealthManagement.com posted an article titled Rob Arnott Says You’ll Be Sorry For Ignoring Smart Beta Warnings. Arnott notes that part of the outperformance broadly speaking has come from money flowing into these funds creating something of a self-fulfilling cycle. As a reminder, Arnott was very early to smart beta (or any of the other terms you […]
